Clench MR - Search Results

1

Multimodal Mass Spectrometry Imaging of an Osteosarcoma Multicellular Tumour Spheroid Model to Investigate Drug-Induced Response.

Pearce SM, Cross NA, Smith DP, Clench MR, Flint LE, Hamm G, Goodwin R, Langridge JI, Claude E, Cole LM. Pearce SM, et al. Among authors: clench mr. Metabolites. 2024 May 29;14(6):315. doi: 10.3390/metabo14060315. Metabolites. 2024. PMID: 38921450 Free PMC article.

2

Mass spectrometry imaging tools in oncology.

Cole LM, Clench MR. Cole LM, et al. Among authors: clench mr. Biomark Med. 2015;9(9):863-8. doi: 10.2217/bmm.15.61. Epub 2015 Sep 2. Biomark Med. 2015. PMID: 26330284 Review.

3

Characterization of an Aggregated Three-Dimensional Cell Culture Model by Multimodal Mass Spectrometry Imaging.

Flint LE, Hamm G, Ready JD, Ling S, Duckett CJ, Cross NA, Cole LM, Smith DP, Goodwin RJA, Clench MR. Flint LE, et al. Among authors: clench mr. Anal Chem. 2020 Sep 15;92(18):12538-12547. doi: 10.1021/acs.analchem.0c02389. Epub 2020 Aug 14. Anal Chem. 2020. PMID: 32786495 Free PMC article.

4

Comparison of Osteosarcoma Aggregated Tumour Models with Human Tissue by Multimodal Mass Spectrometry Imaging.

Flint LE, Hamm G, Ready JD, Ling S, Duckett CJ, Cross NA, Cole LM, Smith DP, Goodwin RJA, Clench MR. Flint LE, et al. Among authors: clench mr. Metabolites. 2021 Jul 31;11(8):506. doi: 10.3390/metabo11080506. Metabolites. 2021. PMID: 34436447 Free PMC article.

5

Multi-Modal Mass Spectrometric Imaging of Uveal Melanoma.

Cole LM, Handley J, Claude E, Duckett CJ, Mudhar HS, Sisley K, Clench MR. Cole LM, et al. Among authors: clench mr. Metabolites. 2021 Aug 23;11(8):560. doi: 10.3390/metabo11080560. Metabolites. 2021. PMID: 34436501 Free PMC article.

6

Perspective: Mass Spectrometry Imaging - The Next 5 Years.

Clench MR, Cole LM. Clench MR, et al. Methods Mol Biol. 2023;2688:203-210. doi: 10.1007/978-1-0716-3319-9_17. Methods Mol Biol. 2023. PMID: 37410295

7

Recombinant " IMS TAG" proteins--a new method for validating bottom-up matrix-assisted laser desorption/ionisation ion mobility separation mass spectrometry imaging.

Cole LM, Mahmoud K, Haywood-Small S, Tozer GM, Smith DP, Clench MR. Cole LM, et al. Among authors: clench mr. Rapid Commun Mass Spectrom. 2013 Nov 15;27(21):2355-62. doi: 10.1002/rcm.6693. Rapid Commun Mass Spectrom. 2013. PMID: 24097391

8

Mass spectrometry imaging for the proteomic study of clinical tissue.

Cole LM, Clench MR. Cole LM, et al. Among authors: clench mr. Proteomics Clin Appl. 2015 Apr;9(3-4):335-41. doi: 10.1002/prca.201400103. Epub 2015 Mar 23. Proteomics Clin Appl. 2015. PMID: 25620724 Review.

9

Mass Spectrometry Imaging of 3D Tissue Models.

Russo C, Lewis EEL, Flint L, Clench MR. Russo C, et al. Among authors: clench mr. Proteomics. 2018 Jul;18(14):e1700462. doi: 10.1002/pmic.201700462. Epub 2018 May 28. Proteomics. 2018. PMID: 29687599

10

Mass spectrometry imaging of endogenous metabolites in response to doxorubicin in a novel 3D osteosarcoma cell culture model.

Palubeckaitė I, Crooks L, Smith DP, Cole LM, Bram H, Le Maitre C, Clench MR, Cross NA. Palubeckaitė I, et al. Among authors: clench mr. J Mass Spectrom. 2020 Apr;55(4):e4461. doi: 10.1002/jms.4461. Epub 2019 Dec 2. J Mass Spectrom. 2020. PMID: 31654532

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters